← back to search

Thomas Eschenhagen

Universität Hamburg · DE
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Tissue Engineering and Regenerative Medicine, Cardiac electrophysiology and arrhythmias, Cardiomyopathy and Myosin Studies, and Electrospun Nanofibers in Biomedical Applications.
h-index
95
citations
31,077
works
651
NIH funding
primary concept
Medicine
email

Recent publications

Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy
Circulation 2025cited by 7position: middledoi
Metabolic Communication by SGLT2 Inhibition
Circulation 2023cited by 127position: middledoi
The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies
Clinical Research in Cardiology 2023cited by 22position: middledoi
PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes
Cell stem cell 2022cited by 94position: middledoi
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Utrecht University Repository (Utrecht University) 2022cited by 66position: middle
Impairment of the ER/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation
EMBO Molecular Medicine 2021cited by 62position: middledoi
In vivo grafting of large engineered heart tissue patches for cardiac repair
JCI Insight 2021cited by 62position: middledoi
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
European Journal of Heart Failure 2021cited by 54position: middledoi
FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo
JACC Basic to Translational Science 2021cited by 19position: middledoi
Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes
Journal of Molecular and Cellular Cardiology 2021cited by 13position: middledoi
Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy
Stem Cell Research 2021cited by 7position: middledoi
PPARdelta signaling activation improves metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: middledoi
Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes
Cell Reports 2020cited by 400position: middledoi
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
Cardiovascular Research 2020cited by 268position: middledoi
Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function
Cardiovascular Research 2020cited by 196position: middledoi
Common Mechanistic Pathways in Cancer and Heart Failure. A Scientific Roadmap on Behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
European Journal of Heart Failure 2020cited by 176position: middledoi
Targeting muscle-enriched long non-coding RNA <i>H19</i> reverses pathological cardiac hypertrophy
European Heart Journal 2020cited by 117position: middledoi
Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction
Nature Communications 2020cited by 105position: middledoi
‘Corrigendum to “Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia” [Molecular Metabolism 5 (2) (2015) 67–78]’
Molecular Metabolism 2020cited by 1position: middledoi
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure
Cardiovascular Research 2019cited by 122position: middledoi
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis
Molecular Therapy — Nucleic Acids 2019cited by 114position: middledoi
Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue
Cardiovascular Research 2019cited by 48position: lastdoi
Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering
Cell Reports 2018cited by 319position: middledoi
Treatments targeting inotropy
European Heart Journal 2018cited by 225position: middledoi
Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats
Journal of Molecular and Cellular Cardiology 2018cited by 65position: lastdoi
Satellite cells delivered in their niche efficiently generate functional myotubes in three-dimensional cell culture
PLoS ONE 2018cited by 50position: middledoi
Cardiomyocyte Regeneration: A Consensus Statement.
PubMed 2017cited by 407position: firstdoi
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure
European Heart Journal 2016cited by 240position: middledoi
<i>S</i> ‐glutathiolation impairs phosphoregulation and function of cardiac myosin‐binding protein C in human heart failure
The FASEB Journal 2016cited by 36position: middledoi
Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization
Journal of the American College of Cardiology 2015cited by 114position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marc N. Hirt · Universität Hamburg7 papers (2015–2021)Thomas Thum · Fraunhofer Research Institution for Materials Recycling and Resource Strategies IWKS6 papers (2013–2021)Lucie Carrier · Universität Hamburg6 papers (2012–2021)Arne Hansen · University Medical Center Hamburg-Eppendorf6 papers (2013–2021)Jan Fiedler · Medizinische Hochschule Hannover4 papers (2013–2019)Ke Xiao · China Medical University3 papers (2015–2020) · 3 papers (2015–2020)Johannes Backs · Helmholtz Association of German Research Centres3 papers (2015–2021)Annette Just · Medizinische Hochschule Hannover3 papers (2013–2019) · 3 papers (2015–2021)Rosalinda Madonna · Istituto Nazionale per le Ricerche Cardiovascolari2 papers (2016–2019)Ariana Foinquinos · AstraZeneca (Sweden)2 papers (2019–2020)Lorenz Lehmann · German Center for Lung Research2 papers (2015–2020)Derek J. Hausenloy · National University of Singapore2 papers (2016–2019)Christian U. Oeing · Heidelberg University2 papers (2015–2020) · 2 papers (2018–2021)Cinzia Perrino · Ceinge Biotecnologie Avanzate (Italy)2 papers (2016–2019)Jonathan Leor · Tel Aviv University2 papers (2016–2019)Katrin Eichelbaum · Max Delbrück Center2 papers (2015–2020)Dorothee Hartmann · Medizinische Hochschule Hannover2 papers (2013–2015)